Descriptive analysis and prognostic factors in cats with myeloma‐related disorders: A multicenter retrospective study of 50 cases

Autor: Lorris Lecot, Isabelle Desmas‐Bazelle, Sarah Benjamin, Pauline De Fornel, Frédérique Ponce, Matthew Kornya, Loïc Desquilbet, Claire Beaudu‐Lange, Catherine Ibisch, David Sayag, Ghita Benchekroun, Jérémy Béguin

Publikováno v: Journal of Veterinary Internal Medicine, Vol 38, Iss 3, Pp 1693-1705 (2024)

Abstract Background Myeloma‐related disorders (MRDs) are rare and poorly documented neoplasms of cats. Hypothesis/Objectives To describe clinical, clinicopathologic, and imaging findings, response to treatment, and survival time and to identify fac

Externí odkaz: https://doaj.org/article/9a1c29812344434999f90fc7246796c2

Implication of Netrin-1 Gain of Expression in Canine Nodal Lymphoma

Autor: Antonin Tortereau, Nadège Milhau, Elodie Rhumy, Marie Castets, Frédérique Ponce, Patrick Mehlen, Thierry Marchal

Publikováno v: Veterinary Sciences, Vol 9, Iss 9, p 494 (2022)

Netrin-1 is a member of the laminin superfamily, and is known to interact with specific receptors, called dependence receptors. While upon netrin-1 binding these receptors initiate positive signaling, in absence of netrin-1, these receptors trigger a

Externí odkaz: https://doaj.org/article/df3b5d9b63334e44bf96d07fc09af039

Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs

Autor: Pauline Denoeux, Gabriel Chamel, Philippe Berny, Thomas Chavalle, Frédérique Ponce, Mathilde Lajoinie, David Sayag

Publikováno v: Veterinary and Comparative Oncology. 20:393-403

Overall prevalence of severe adverse events (sAE) has been poorly studied in veterinary medicine and peer-reviewed studies mostly focused on a single protocol, making it difficult to have a general overview. The aim of this retrospective study was to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e772b4bb1b74df93fad5267abc97e65
https://doi.org/10.1111/vco.12782

Therapeutic efficacy of

Autor: Mehrdad, Khoshnevis, Richard, Brown, Sara, Belluco, Ilyes, Zahi, Luca, Maciocco, Catherine, Bonnefont-Rebeix, Elodie, Pillet-Michelland, Jonathan, Tranel, Thierry, Roger, Christophe, Nennig, Patrick, Oudoire, Lionel, Marcon, Olivier, Tillement, Cédric, Louis, Hélène, Gehan, Manuel, Bardiès, Maurizio, Mariani, Valeria, Muzio, Jean-Philippe, Meunier, Charlotte, Duchemin, Nathalie, Michel, Estelle, N'Tsiba, Ferid, Haddad, Thierry, Buronfosse, Claude, Carozzo, Frédérique, Ponce

Publikováno v: Frontiers in oncology. 12

Glioblastoma is considered the most common malignant primary tumor of central nervous system. In spite of the current standard and multimodal treatment, the prognosis of glioblastoma is poor. For this reason, new therapeutic approaches need to be dev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f6682c05cb0d46b741e1eaababf1710b
https://pubmed.ncbi.nlm.nih.gov/36419904

Feasibility of intratumoral 165Holmium siloxane delivery to induced U87 glioblastoma in a large animal model, the Yucatan minipig

Autor: Cédric Louis, Lionel Marcon, Mehrdad Khoshnevis, Catherine Bonnefont-Rebeix, Frédérique Ponce, Thierry Buronfosse, T. Roger, Claude Carozzo, Richard Brown, Manuel Bardiès, Olivier Tillement, Hélène Gehan, Christophe Nennig, Sara Belluco, Ilyes Zahi

Publikováno v: PLoS ONE
PLoS ONE, 2020, 15 (6), pp.e0234772. ⟨10.1371/journal.pone.0234772⟩
PLoS ONE, Public Library of Science, 2020, 15 (6), pp.e0234772. ⟨10.1371/journal.pone.0234772⟩
PLoS ONE, Vol 15, Iss 6, p e0234772 (2020)

International audience; Glioblastoma is the most aggressive primary brain tumor leading to death in most of patients. It comprises almost 50-55% of all gliomas with an incidence rate of 2-3 per 100,000. Despite its rarity, overall mortality of gliobl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::128548ab9e9048f662cf158be98a0e6c
https://www.hal.inserm.fr/inserm-02907080/document